Insights

HELIX alpha is further strengthening its European platform and expanding the specialist capabilities it offers across Life Science Real Estate. As of 1 October 2026, Patrick Schlump will join HELIX alpha as Managing Partner and shareholder, taking a leading role in Fund Management, Client Relations and Equity Raising. Most recently with France-based Praemia REIM, Patrick brings extensive experience in European investment and fund management. He and HELIX alpha founder and CEO

Martin Eberhardt FRICS, CEO & Founder of HELIX alpha, spoke at the CBRE Life Sciences Summit in Berlin on the topic of “Infrastructure & Capitalization Gap in Life Science Real Estate”. The summit brought together senior representatives from across the European Life Science Real Estate sector, including corporates, developers, investors, operators, banks and advisors, to discuss the requirements for the further development of the sector and the role of real estate and capital

Martin Eberhardt FRICS, CEO & Founder of HELIX alpha, will participate in a panel discussion on the specific challenges of valuing Social Infrastructure, including Life Science Real Estate, at the RICS Valuation Conference in Frankfurt am Main on 22 September 2026. The valuation of Life Science Real Estate presents particular challenges for valuers and investors. The European market is still comparatively young, with a limited number of investment transactions and reliable co

HELIX alpha recently supported a university research project led by Professor Dr. Bernd Wieberneit at Hochschule RheinMain as part of the Master's programme International Investment and Asset Management. During the second semester, student teams prepared graded research projects analysing the investment attractiveness of six European Life Science Real Estate markets: Denmark, Ireland, Spain, France, Sweden and the Netherlands. HELIX alpha accompanied the project throughout th

Laboratory real estate is evolving into one of the most complex and mission-critical infrastructure asset classes in Europe. As part of a recent expert panel hosted by Potsdam Science Park on “Safety in Laboratory Operations and Laboratory Design,” HELIX alpha contributed perspectives from an investor and developer standpoint on the structural transformation currently shaping the European life science real estate market. The discussion focused on several key tensions increasi

HELIX alpha holds regular meetings between its Investment & Risk Committee and Advisory Board throughout the year, complemented by an annual in-person session. The most recent meeting took place in Hamburg. The session focused on reviewing and further refining the core premises of HELIX alpha’s investment strategy. Particular emphasis was placed on the continued focus on both emerging and established life science clusters across Europe as the foundation for disciplined invest

As part of its pan-European investment strategy, HELIX alpha actively engages with leading life science clusters to build direct relationships with key ecosystem stakeholders. In this context, HELIX alpha recently visited the Stockholm life science cluster together with its local Country Representative. The exchange included meetings with senior representatives of established cluster organisations, providing on-the-ground insights into one of Europe’s most advanced and intern

HELIX alpha participated as an official partner in a recent industry event on Life Science Real Estate (LSRE) hosted by Heuer Dialog. The conference highlighted the growing institutional relevance of LSRE as an emerging and structurally differentiated asset class. The discussions reflected a holistic perspective across the value chain – from market analysis and development expertise to user requirements and cluster dynamics. In particular, the role of established and emerging